Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00164502
Status:
COMPLETED
Last Update Posted:
2005-09-14
First Post:
2005-09-12
Brief Title:
Limb Loss Self-Management Program
Sponsor:
Centers for Disease Control and Prevention
Organization:
Centers for Disease Control and Prevention
Study Overview
Official Title:
Limb Loss Self-Management Program Promoting Amputee Life Skills
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the project is to develop and test the efficacy of a community-based self-management intervention for reducing pain depression and improving self-efficacy and function in person with limb loss
Detailed Description:
Approximately 12 million Americans are living with the loss of a limb and the incidence is increasing due to increases in the prevalence of diabetes Pain emotional distress reduced functional abilities are common conditions following limb loss and reduce quality of life Self-management interventions have been found to be effective in reducing the secondary conditions associated with arthritis and diabetes Self management uses the principles of cognitive-behavioral therapy including education self monitoring problem solving and skill acquisition
The goal of the project is to develop and test the efficacy of a community based self management intervention for reducing pain depression and improving self efficacy and function in persons with limb loss using a randomized controlled design
50 groups of 8-10 persons will be randomized to either a control group or a treatment group
The goal of the project is to develop and test the efficacy of a community based self management intervention for reducing pain depression and improving self efficacy and function in persons with limb loss using a randomized controlled design
50 groups of 8-10 persons will be randomized to either a control group or a treatment group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None